Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins [clinicaltrials_resource:1c093611be3e86ea0559d25d53beea00]
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment [clinicaltrials:NCT00005639]Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory AIDS-Related Lymphoma [clinicaltrials:NCT00005824]clinicaltrials:NCT00016354Motexafin Gadolinium in Treating Patients With Glioblastoma Multiforme Who Are Undergoing Radiation Therapy to the Brain [clinicaltrials:NCT00032097]Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00064285]VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia [clinicaltrials:NCT00083187]clinicaltrials:NCT00084383Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer [clinicaltrials:NCT00311623]clinicaltrials:NCT00361296High-Dose Cyclophosphamide in Treating Patients With Acute Graft-Versus-Host Disease That Did Not Respond to Steroid Therapy [clinicaltrials:NCT00492921]clinicaltrials:NCT00946023Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma [clinicaltrials:NCT01045460]Dose-Escalation Phase 1 Study of G-202 in Patients With Advanced Solid Tumors [clinicaltrials:NCT01056029]Study of Intravenous TCD-717 in Patients With Advanced Solid Tumors [clinicaltrials:NCT01215864]A Trial to Evaluate Two Schedules of MS275 in Combination With 5AC in Elderly Patients With Acute Myeloid Leukemia (AML) [clinicaltrials:NCT01305499]clinicaltrials:NCT01349569Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma [clinicaltrials:NCT01438554]
location [clinicaltrials_vocabulary:location]
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins [clinicaltrials_resource:1c093611be3e86ea0559d25d53beea00]
Bio2RDF identifier
1c093611be3e86ea0559d25d53beea00
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1c093611be3e86ea0559d25d53beea00
address [clinicaltrials_vocabulary:address]
identifier
clinicaltrials_resource:1c093611be3e86ea0559d25d53beea00
title
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
@en
type
label
Sidney Kimmel Comprehensive Ca ...... 93611be3e86ea0559d25d53beea00]
@en